Tech Company Financing Transactions
Constellation Pharmaceuticals Funding Round
Constellation Pharmaceuticals secured a $15 million Series B funding round on 6/6/2011. Investors included SR One Capital Management, The Column Group and Third Rock Ventures.
Transaction Overview
Company Name
Announced On
6/6/2011
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Series B
Investors
Proceeds Purpose
Proceeds from this round of financing will allow the company to continue to advance product candidates in its portfolio toward clinical development.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
215 First St. 200
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Website
Email Address
Overview
Constellation Pharmaceuticals (Nasdaq: CNST) is the leading biopharmaceutical company dedicated to the development of novel therapeutics in the emerging field of epigenetics.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jigar Raythatha
Chief Financial Officer
Emma Reeve
Chief Medical Officer
Adrian Senderowicz
Vice President
Patrick Trojer
VP - Bus. Development
Brad Prosek
VP - Human Resources
Brenda Sousa
Browse more venture capital transactions:
Prev: 6/6/2011: Backplane Social venture capital transaction
Next: 6/6/2011: Adaptive Biotechnologies venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs